Background Phosphate binders are used to reduce positive phosphate balance and to lower
serum phosphate levels for people with chronic kidney disease (CKD) with the aim to …

Hyperphosphatemia, which is nearly universal in kidney failure, is accompanied by low
serum levels of vitamin D and hypocalcemia. Without treatment, severe secondary …

The biological properties of the lanthanides, based on their similarity to calcium, have
stimulated research into their therapeutic application. Historical medical uses of the …

Hyperphosphatemia in chronic kidney disease (CKD) patients is a potentially life altering
condition that can lead to cardiovascular calcification, metabolic bone disease (renal …

Phosphate binders include calcium acetate or carbonate, sevelamer hydrochloride or
carbonate, magnesium and lanthanum carbonate, and aluminum carbonate or hydroxide …

Background. In chronic kidney disease (CKD) patients, the ability to excrete a phosphate
load is impaired. Compensatory increase in parathyroid hormone (PTH) and fibroblast …

BACKGROUND: Phosphate binders are widely used to control serum phosphorus levels in
patients with chronic kidney disease (CKD). We analyzed the effects of phosphate binders …

Background. Phosphate binders are required to control serum phosphorus in dialysis
patients. A phosphate binder combining calcium and magnesium offers an interesting …

Cardiovascular (CV) disease (CVD) accounts for> 50% of deaths with known causes in
patients on dialysis. Elevated serum phosphorus levels are an important nontraditional risk …

Objectives: This review explores the challenges and solutions in educating patients with
chronic kidney disease (CKD) to lower serum phosphorus while avoiding protein …